期刊文献+

前列腺癌生物学行为与端粒酶活性表达的相关性研究 被引量:2

RELATIONSHIP BETWEEN TELOMERASE ACTIVITY AND THE BIOLOGICAL BEHAVIOR OF PROSTATE CANCER
原文传递
导出
摘要 目的 :研究前列腺癌组织中端粒酶活性表达与前列腺癌生物学行为的关系。方法 :采用端粒重复序列扩增文件—酶标法 (TRAP- EL ISA)测定前列腺癌组织中端粒酶活性。结果 :10例正常前列腺组织无端粒酶活性。 15例前列腺癌组织中 13例检出端粒酶活性 ,阳性率 86 .0 %。端粒酶活性与肿瘤分化程度相关。 12例良性前列腺增生组织中 2例检出端粒酶活性 ,阳性率为 17.0 % ,其水平显著低于肿瘤组织。结论 :端粒酶活性与前列腺癌的生物学行为相关 ,能估测前列腺癌的生物恶性潜力。 Objective:To investigate the relationship between telomerase activity and the biological behavior of prostate cancer.Methods:The telomerase activity in prostate cancer tissues was detected by TRAP (telomeric repeat amplification protocol) ELISA which is based upon amplification of the initial telomerase product and detected by ELISA.Results:None of the 10 samples from normal prostates expressed telomerase activity.The thirteen of fifteen cases (86.0%) with prostate cancer presented telomerase activity.The activity of telomerase was associated with the pathological differentiation of prostate cancer.The two of twelve cases (17.0%) with benign prostatic hyperplasia (BPH) expressed telomerase activity,and the activity of telomerase was lower than prostate cancer.Conclusion:The telomerase acitivity may be related to the biological behavior of prostate cancer and can evaluate the malignant potential of prostate cancer.The presence of telomerase acitivity in some cases of BPH may indicate the presence of a minority of malignant cells,as yet clinically undetected,within the population of BPH cells.
出处 《肿瘤研究与临床》 CAS 2001年第6期395-397,共3页 Cancer Research and Clinic
关键词 前列腺肿瘤 端粒酶 免疫酶技术 病理 Prostatic neoplasms Telomerase Immunoenzyme techniques
  • 相关文献

参考文献6

  • 1Goldstein S.Replicative: The human fibroblast comes of age[].Science.1990
  • 2Harley C B.Telomerase and cancer[].Important Advances in Oncology.1996
  • 3Scates D K,Muir G H,Venitffs H K,et al.Detection of telomerase activity in human prostate: a diagnostic marker for prostatic cancer[].British Journal of Urology.1997
  • 4Sommerfield H J,Meeker A K,Piatyszek M A,et al.Telomerase activity: a prevalent marker of malignant human prostate tissue[].Cancer Research.1996
  • 5Kim N W,Piatyszek M A,Prowse K K,et al.Specific association of human telomerase acitivty with immortal cells and cancer[].Science.1994
  • 6Feng J,Kuck W D,Wang S S,et al.The RNA componenet of human telomerase[].Science.1995

同被引文献18

  • 1谭善峰.端粒酶在前列腺癌组织中的活性表达及意义[J].中国医药指南,2007,5(4):91-94. 被引量:2
  • 2[1]Sommerfid HJ,Meeker AK,Piatvszek,et al.Telomerase activity:a prevalent marker of malignant human prostate tissue[J].Cancer Res,1996,56(2):218-222.
  • 3[2]Kim NW,Piatysvek MA,Prowse KK,et al.Specific association of human telomerase activity with immortal cels and cancer[J].Science,1994,266(5):2011.
  • 4[3]Lichtsteiner SP,Lebkowski JS,Vasserot AP,et al.Telomerase a target for anticancer the rapy[J].Ann N Y Acad Sci,1999,866(1):1-11.
  • 5[4]Scares DK,Muir GH,Venitff S,et al.Detection of telomerase activity in human prostate:a diagnostic marker for prostatic cancer?[J]Br J Urology,2002,80(7):263.
  • 6[6]Lin Y,Uemura H,Fujinami K,et al.Telomerase activity in primary prostate cancer[J].J Urol,1997,157(3):1161-1165.
  • 7[7]Zhang W,Kapusta LR,Slingerlaand JM,et al.Telomerase activity in Prostate cancer,prostatic intraepithelial neoplasia and benign prostatic epthelim[J] Cancer Res,2004,58(2):619-621.
  • 8[8]Meid FH,Gygi CM,Leisinger HJ,et al.The use of telomerase activity for the detection of prostatic cancer cells after prostatic message[J].J Urol,2005,165(5):1802-1805.
  • 9于小玲,谢俊霞.前列腺癌组织中分化抑制蛋白1相互结合蛋白的分离[J].中华男科学杂志,2008,14(9):796-799. 被引量:1
  • 10赵易,武国军,张瑞,沈岚,于垂恭,王映梅,药立波,袁建林.PRL-3在前列腺癌组织中的表达及其意义[J].实用医学杂志,2010,26(1):39-41. 被引量:8

引证文献2

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部